IPO Profile: Canadian company Clementia only VC-backed IPO in August


IPO VC
Only one venture-backed IPO took place in August. The distinction belongs to Montréal biopharmaceutical company Clementia Pharmaceuticals Inc, which last month raised about $120 million from its IPO on the Nasdaq. The news was noted by BDC Capital Healthcare Fund, an investor in Clementia ...

This content is available for Venture Capital subscribers only. Request a free trial to get access for a limited period

Venture Capital

Subscribe Now Request Trial

If you already have an active Venture Capital subscription, please sign in to view this article.

Digital Edition

VCJ_917_cover

To read a digital copy of our latest magazine

click here